Common Contracts
2 similar Investor Rights Agreement contracts by Oncobiologics, Inc., Outlook Therapeutics, Inc.
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT by and between Outlook Therapeutics, Inc. and GMS VENTURES AND INVESTMENTS Dated April 21, 2022Investor Rights Agreement • April 22nd, 2022 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT, dated as of April 21, 2022 (this “Agreement”), is by and between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and GMS Ventures and Investments, a company incorporated under the laws of Cayman Islands (the “Shareholder”). The Shareholder and the Company are referred to hereinafter each as a “Party” and collectively as the “Parties.”
INVESTOR RIGHTS AGREEMENT by and between ONCOBIOLOGICS, Inc. and GMS TENSHI HOLDINGS PTE. LIMITED Dated September 11, 2017Investor Rights Agreement • September 11th, 2017 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York
This INVESTOR RIGHTS AGREEMENT, dated as of September 11, 2017 (this “Agreement”), is by and between Oncobiologics, Inc., a Delaware corporation (the “Company”), and GMS Tenshi Holdings Pte. Limited, a Singapore private limited company (the “Shareholder”). The Shareholder and the Company are referred to hereinafter each as a “Party” and collectively as the “Parties.”
